HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min Xia Selected Research

malealdehyde

9/2006[Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease].
6/2006[Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min Xia Research Topics

Disease

34Atherosclerosis
02/2022 - 03/2003
20Inflammation (Inflammations)
02/2022 - 03/2003
19Neoplasms (Cancer)
01/2022 - 06/2009
18Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 10/2010
15Hyperhomocysteinemia
01/2016 - 04/2004
14Coronary Artery Disease (Coronary Atherosclerosis)
10/2021 - 06/2006
13Obesity
01/2022 - 09/2010
12Infections
10/2021 - 03/2011
12Insulin Resistance
01/2021 - 03/2007
9Type 2 Diabetes Mellitus (MODY)
01/2020 - 11/2012
8Hypertension (High Blood Pressure)
11/2021 - 05/2008
8Atherosclerotic Plaque (Atheroma)
01/2020 - 03/2003
8Non-alcoholic Fatty Liver Disease
10/2018 - 05/2011
8Sclerosis
01/2016 - 09/2009
7Proteinuria
09/2014 - 04/2010
6Hypoxia (Hypoxemia)
12/2020 - 05/2008
6Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019 - 09/2010
6Hypercholesterolemia
10/2017 - 07/2010
6Mitochondrial Diseases (Mitochondrial Disease)
11/2016 - 06/2009
6Albuminuria
09/2014 - 10/2011
5Neoplasm Metastasis (Metastasis)
01/2020 - 01/2015
4Breast Neoplasms (Breast Cancer)
01/2022 - 01/2011
4Carcinogenesis
01/2022 - 10/2012
4Asthma (Bronchial Asthma)
06/2021 - 01/2015
4Lymphatic Metastasis
02/2021 - 01/2015
3Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2011
3Hyperglycemia
01/2021 - 01/2012
3Pathologic Processes
01/2021 - 06/2013
3Endometrial Neoplasms (Endometrial Cancer)
01/2021 - 04/2016
3Body Weight (Weight, Body)
08/2020 - 09/2010
3Melanoma (Melanoma, Malignant)
04/2020 - 05/2006
3Myocardial Infarction
11/2017 - 09/2013
3Leukemia
01/2016 - 09/2010
3Hypertriglyceridemia
05/2015 - 01/2014
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2013 - 06/2009
3Diabetes Mellitus
08/2013 - 12/2010
2Cognitive Dysfunction
01/2022 - 01/2020
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 05/2014
2Cerebral Hemorrhage
11/2021 - 01/2020
2Hemorrhage
11/2021 - 01/2020
2Respiratory Tract Diseases (Respiratory Tract Disease)
06/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2010
21CholesterolIBA
01/2021 - 03/2003
16InflammasomesIBA
01/2021 - 04/2012
15ApolipoproteinsIBA
02/2022 - 03/2003
15Anthocyanins (Anthocyanin)IBA
04/2015 - 08/2006
14Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2011
13LipidsIBA
01/2022 - 09/2009
13Apolipoproteins E (ApoE)IBA
01/2020 - 03/2003
11HomocysteineIBA
10/2021 - 04/2004
10MicroRNAs (MicroRNA)IBA
01/2021 - 01/2014
9Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2008
9Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
01/2020 - 08/2013
8Small Interfering RNA (siRNA)IBA
04/2016 - 03/2007
8Reactive Oxygen Species (Oxygen Radicals)IBA
06/2015 - 03/2008
7Triglycerides (Triacylglycerol)IBA
01/2021 - 04/2011
7Insulin (Novolin)FDA Link
08/2020 - 03/2007
7AdipokinesIBA
01/2019 - 12/2010
7CeramidesIBA
10/2017 - 09/2009
6S-AdenosylhomocysteineIBA
02/2022 - 02/2008
6AntioxidantsIBA
01/2022 - 01/2007
6Pharmaceutical PreparationsIBA
10/2020 - 06/2004
6NADPH Oxidases (NAD(P)H oxidase)IBA
09/2014 - 09/2009
5CytokinesIBA
01/2022 - 01/2014
5Antiviral Agents (Antivirals)IBA
10/2021 - 07/2012
5NLR ProteinsIBA
01/2021 - 07/2012
5Nicotinamide PhosphoribosyltransferaseIBA
01/2019 - 02/2011
5Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2017 - 07/2015
5SaltsIBA
11/2014 - 05/2008
5SNX 2112IBA
03/2014 - 06/2009
4Angiotensin IIIBA
11/2021 - 10/2011
4AcidsIBA
10/2017 - 11/2011
4Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
10/2017 - 11/2011
4oxidized low density lipoproteinIBA
07/2013 - 09/2005
4Superoxides (Superoxide)IBA
06/2013 - 01/2009
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013 - 11/2005
3LectinsIBA
01/2021 - 01/2020
3CollagenIBA
01/2021 - 06/2016
3EnzymesIBA
01/2021 - 09/2010
3Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 02/2016
3Superoxide DismutaseIBA
01/2020 - 06/2006
3AntigensIBA
06/2016 - 10/2010
3NucleotidesIBA
01/2016 - 01/2014
3Apolipoproteins B (ApoB)IBA
05/2015 - 10/2010
3AdiponectinIBA
04/2015 - 07/2013
3Methionine (L-Methionine)FDA Link
01/2015 - 04/2004
3Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2014 - 12/2012
3Aryldialkylphosphatase (Paraoxonase)IBA
02/2014 - 06/2006
3NADP (NADPH)IBA
02/2014 - 01/2009
3Peptides (Polypeptides)IBA
01/2013 - 10/2010
32- (4- acetyloxycyclohexylamino)- 4- (3,6,6- trimethyl- 4- oxo- 4,5,6,7- tetrahydro- 1H- indazol- 1- yl)- benzamideIBA
12/2012 - 03/2011
3Transcription Factors (Transcription Factor)IBA
04/2012 - 05/2008
3Folic Acid (Vitamin M)FDA LinkGeneric
04/2010 - 04/2004
2tetracarboxyphenylporphineIBA
01/2022 - 03/2021
2Hemoglobins (Hemoglobin)IBA
11/2021 - 01/2021
2Circulating Tumor DNAIBA
10/2021 - 11/2018
2Long Noncoding RNAIBA
10/2021 - 01/2020
2Particulate MatterIBA
06/2021 - 01/2021

Therapy/Procedure

11Therapeutics
10/2021 - 09/2011
3Renal Dialysis (Hemodialysis)
01/2022 - 12/2018